These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8825929)

  • 61. Detection of four novel mutations in the porphobilinogen deaminase gene in French Caucasian patients with acute intermittent porphyria.
    Puy H; Deybach JC; Lamoril J; Robreau AM; Nordmann Y
    Hum Hered; 1996; 46(3):177-80. PubMed ID: 8860014
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of the mutations in the parents of a patient with a putative compound heterozygosity for acute intermittent porphyria.
    Picat C; Delfau MH; de Rooij FW; Beukeveld GJ; Wolthers BG; Wadman SK; Nordmann Y; Grandchamp B
    J Inherit Metab Dis; 1990; 13(5):684-6. PubMed ID: 2246852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Frequency of low erythrocyte porphobilinogen deaminase activity in Finland.
    Mustajoki P; Kauppinen R; Lannfelt L; Lilius L; Koistinen J
    J Intern Med; 1992 Apr; 231(4):389-95. PubMed ID: 1588264
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP).
    Granata F; Mendez M; Brancaleoni V; Castelbon FJ; Graziadei G; Ventura P; Di Pierro E
    Mol Genet Metab; 2018 Nov; 125(3):295-301. PubMed ID: 30201327
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria.
    Pierach CA; Weimer MK; Cardinal RA; Bossenmaier IC; Bloomer JR
    JAMA; 1987 Jan; 257(1):60-1. PubMed ID: 3783903
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study.
    Andersson C; Floderus Y; Wikberg A; Lithner F
    Scand J Clin Lab Invest; 2000 Nov; 60(7):643-8. PubMed ID: 11202057
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: evidence for an ancestral founder of the common G111R mutation.
    De Siervi A; Rossetti MV; Parera VE; Astrin KH; Aizencang GI; Glass IA; Batlle AM; Desnick RJ
    Am J Med Genet; 1999 Oct; 86(4):366-75. PubMed ID: 10494093
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Frameshift mutations in exons 9 and 10 of the porphobilinogen deaminase gene produce a crossreacting immunological material (CRIM)-negative form of acute intermittent porphyria.
    Schreiber WE; Fong F; Jamani A
    Hum Genet; 1994 May; 93(5):552-6. PubMed ID: 8168833
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acute intermittent porphyria caused by a single base insertion of C in exon 15 of the porphobilinogen deaminase gene that results in a frame shift and premature stopping of translation.
    Daimon M; Yamatani K; Igarashi M; Fukase N; Morita Y; Ogawa A; Tominaga M; Sasaki H
    Hum Genet; 1994 May; 93(5):533-7. PubMed ID: 8168829
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular study of the hydroxymethylbilane synthase gene (HMBS) among Polish patients with acute intermittent porphyria.
    Gregor A; Schneider-Yin X; Szlendak U; Wettstein A; Lipniacka A; Rüfenacht UB; Minder EI
    Hum Mutat; 2002 Mar; 19(3):310. PubMed ID: 11857754
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Porphobilmogen deaminase gene mutations in Brazilian acute intermittent porphyria patients.
    Ribeiro GS; Marchiori PE; Kuntz Puglia PM; Nagai MA; Dos Santos ML; Nonoyama K; Hirata MH; Barretto OC
    J Clin Lab Anal; 2002; 16(5):259-65. PubMed ID: 12357456
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular analysis of acute intermittent porphyria: mutation screening in 20 patients in Germany reveals 11 novel mutations.
    von Brasch L; Zang C; Haverkamp T; Schlechte H; Heckers H; Petrides PE
    Blood Cells Mol Dis; 2004; 32(2):309-14. PubMed ID: 15003823
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diagnosis of acute intermittent porphyria in northern Sweden: an evaluation of mutation analysis and biochemical methods.
    Andersson C; Thunell S; Floderus Y; Forsell C; Lundin G; Anvret M; Lannfelt L; Wetterberg L; Lithner F
    J Intern Med; 1995 Mar; 237(3):301-8. PubMed ID: 7891051
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acute intermittent porphyria caused by an arginine to histidine substitution (R26H) in the cofactor-binding cleft of porphobilinogen deaminase.
    Llewellyn DH; Whatley S; Elder GH
    Hum Mol Genet; 1993 Aug; 2(8):1315-6. PubMed ID: 8401516
    [No Abstract]   [Full Text] [Related]  

  • 75. [Uroporphyrinogen-I-synthetase in erythrocytes in acute intermittent porphyria].
    Iwanov ED; Adjarov D; Tsanev R
    Acta Biol Med Ger; 1977; 36(5-6):801-4. PubMed ID: 602585
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dual porphyria with mutations in both the UROD and HMBS genes.
    Harraway JR; Florkowski CM; Sies C; George PM
    Ann Clin Biochem; 2006 Jan; 43(Pt 1):80-2. PubMed ID: 16390615
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mutation in the exon 10 (R173W) of the hydroxymethylbilane synthase gene in two unrelated Japanese families with acute intermittent porphyria.
    Tomie Y; Horie Y; Tajima F; Kitaoka S; Nanba E; Yuasa I; Kawasaki H
    Res Commun Mol Pathol Pharmacol; 1998 Jan; 99(1):5-15. PubMed ID: 9523350
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular basis of acute intermittent porphyria: mutations and polymorphisms in the human hydroxymethylbilane synthase gene.
    Astrin KH; Desnick RJ
    Hum Mutat; 1994; 4(4):243-52. PubMed ID: 7866402
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical and Laboratory Features of Acute Porphyria: A Study of 36 Subjects in a Chinese Tertiary Referral Center.
    Yang J; Chen Q; Yang H; Hua B; Zhu T; Zhao Y; Zhu H; Yu X; Zhang L; Zhou Z
    Biomed Res Int; 2016; 2016():3927635. PubMed ID: 28025645
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Porphobilinogen deaminase in acute intermittent porphyria: activity and concentration in erythrocytes and lymphocytes.
    Lilius L; Lannfelt L; Wetterberg L; Floderus Y; Henrichson A; Thunell S
    Clin Chim Acta; 1991 Feb; 197(1):77-84. PubMed ID: 2044216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.